ClinicalTrials.Veeva

Menu

Adaptation of the PROFFIT Instrument Into Turkish: A Validity and Reliability Study

A

Akdeniz University

Status

Not yet enrolling

Conditions

Cancer

Study type

Observational

Funder types

Other
NETWORK

Identifiers

NCT07088978
Akdeniz_University

Details and patient eligibility

About

The aim of this study is to evaluate the Turkish validity and reliability of the Patient Reported Outcomes for Fighting Financial Toxicity of Cancer (PROFFIT) developed in Italy.

Full description

The scale validity of the study will be evaluated through language and content validity, construct validity, criterion validity, and known-group validity methods; while the scale reliability will be assessed by calculating the Cronbach's alpha and McDonald's omega reliability coefficients.

Enrollment

320 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Individuals diagnosed with solid cancer or hematologic malignancy, either histologically or cytologically, and aware of their diagnosis,
  • Those who have received cancer treatment (chemotherapy, targeted therapy, immunotherapy, hormonal therapy, radiotherapy, or a combination of these treatments) within the last three months,
  • Individuals over the age of 18,
  • Those without a diagnosed psychiatric illness (such as depression, panic attacks, schizophrenia, etc.),
  • Individuals without auditory or cognitive impairments,
  • Turkish-speaking and literate volunteers.

Exclusion criteria

  • Individuals who fill out the data collection forms incompletely or wish to withdraw from the study.

Trial contacts and locations

0

Loading...

Central trial contact

Zeynep Özer, PhD; Zeynep Karakuş, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems